360 related articles for article (PubMed ID: 8566880)
1. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
Perfetti V; Garini P; Vignarelli MC; Marinone MG; Zorzoli I; Merlini G
Haematologica; 1995; 80(5):409-15. PubMed ID: 8566880
[TBL] [Abstract][Full Text] [Related]
2. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
3. Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow.
Gertz MA; Greipp PR; Kyle RA
J Lab Clin Med; 1991 Jul; 118(1):33-9. PubMed ID: 1906082
[TBL] [Abstract][Full Text] [Related]
4. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
5. AL-amyloidosis is underdiagnosed in renal biopsies.
Novak L; Cook WJ; Herrera GA; Sanders PW
Nephrol Dial Transplant; 2004 Dec; 19(12):3050-3. PubMed ID: 15507480
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases.
Swan N; Skinner M; O'Hara CJ
Am J Clin Pathol; 2003 Oct; 120(4):610-6. PubMed ID: 14560572
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
9. Light chain types of IgD in human bone marrow and serum.
van Nieuwkoop JA; Radl J
Clin Exp Immunol; 1985 Jun; 60(3):654-60. PubMed ID: 3926359
[TBL] [Abstract][Full Text] [Related]
10. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
11. Primary AL (kappa-light chain) amyloidosis manifesting as peripheral neuropathy in a young male without increase in serum and urine immunoglobulin load: a diagnostic challenge.
Sarkar C; Chand Sharma M; Nayak A; Mercy Ralte A; Gupta V; Singh S; Behari M
Clin Neuropathol; 2005; 24(3):118-25. PubMed ID: 15943163
[TBL] [Abstract][Full Text] [Related]
12. The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients.
Perfetti V; Colli Vignarelli M; Anesi E; Garini P; Quaglini S; Ascari E; Merlini G
Haematologica; 1999 Mar; 84(3):218-21. PubMed ID: 10189385
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of AL amyloidosis in the absence of detectable serum or urinary monoclonal component].
Lantz O; Guettier C; Jouvin MH; Benoit MO; Bariety J; Druet P
Nephrologie; 1986; 7(5):204-6. PubMed ID: 3102983
[TBL] [Abstract][Full Text] [Related]
14. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
Noel LH; Droz D; Ganeval D; Grunfeld JP
Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
[TBL] [Abstract][Full Text] [Related]
15. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders.
Vermeersch P; Vercammen M; Holvoet A; Vande Broek I; Delforge M; Bossuyt X
Clin Chim Acta; 2009 Dec; 410(1-2):54-8. PubMed ID: 19778527
[TBL] [Abstract][Full Text] [Related]
16. Plasma cell hyperplasia and monoclonal paraproteinemia in human immunodeficiency virus-infected patients.
Turbat-Herrera EA; Hancock C; Cabello-Inchausti B; Herrera GA
Arch Pathol Lab Med; 1993 May; 117(5):497-501. PubMed ID: 8489339
[TBL] [Abstract][Full Text] [Related]
17. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.
Levinson SS
Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799
[TBL] [Abstract][Full Text] [Related]
18. [Immunonephelometric analysis of immunoglobulin light chains: agreement between the theoretical and experimental model. Assessment of the reference values of the kappa/lambda ratio and the heavy to light chain ratio].
Chapuis-Cellier C; Cloppet H; Chazaud A; Coquelin H
J Pharm Belg; 1996; 51(1):23-27. PubMed ID: 8882446
[TBL] [Abstract][Full Text] [Related]
19. Amyloidosis of pancreatic islets in primary amyloidosis (AL type).
Tomita T
Pathol Int; 2005 Apr; 55(4):223-7. PubMed ID: 15826250
[TBL] [Abstract][Full Text] [Related]
20. Use of kappa and lambda chain quantitation for the detection of immunoglobulin abnormalities in serum.
Normansell DE
Diagn Clin Immunol; 1987; 5(2):100-3. PubMed ID: 3113758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
